Sexual functioning and SSRIs
by
Fava M, Rankin M.
Depression Clinical and Research Program,
Massachusetts General Hospital,
Boston 02114-3117, USA.
J Clin Psychiatry 2002;63 Suppl 5:13-6; discussion 23-5

ABSTRACT

This article reviews the literature concerning the relationship between sexual functioning and selective serotonin reuptake inhibitors (SSRIs). Reduced sexual functioning is a common depressive symptom that typically improves after successful antidepressant treatment. On the other hand, sexual dysfunction has been observed in a substantial proportion of patients treated with all classes of antidepressants. In particular, SSRI use has been shown to be associated with sexual dysfunction. A number of pharmacologic interventions have been found to be helpful in anecdotal case reports. Unfortunately, the lack of placebo-controlled studies in this area limits our ability to draw firm conclusions on the efficacy of such interventions. Three classes of drugs have primarily been used to counteract sexual side effects of SSRIs: serotonin receptor antagonists, a2-adrenergic receptor antagonists, and dopaminergic agents. An open trial from our group suggests the potential usefulness of oral sildenafil in the treatment of antidepressant-associated sexual side effects, but further studies are needed.

SSRIs
Viagra
Dosage
Serotonin
Bupropion
Yohimbine
Fluoxetine
Amineptine
New SSRIs
Nitric oxide
Moclobemide
Testosterone
Phentolamine
Drugs and sex
Phophodiesterase
Designer aphrodisiacs
Viagra: clinical efficacy
Antidepressants and sex
SSRIs and disinhibited libido?
Dopamine, serotonin and sex
SSRIs and sexual functioning

Refs
and further reading

HOME
HedWeb
Nootropics
cocaine.wiki
Future Opioids
BLTC Research
MDMA/Ecstasy
Superhapiness?
Utopian Surgery?
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World

The Good Drug Guide
The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family